9.76€
-0.07€ (-0.72%)
End-of-day quote: 05/17/2024
XTRA:EVT
Evotec Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| IDXX | IDEXX Laboratories | NasdaqGS | Outperform | $530.07 | $583.92 | 0.00% | 0 | $43.78B |
| IQV | IQVIA Holdings | NYSE | Outperform | $230.09 | $267.27 | 0.00% | 19 | $41.92B |
| ICLR | ICON Public | NasdaqGS | Buy | $318.72 | $306.07 | 0.00% | 1 | $26.35B |
| ARGX | argenx | ENXTBR | Outperform | 334.60€ | 531.81€ | 0.00% | 10 | 19.89€B |
| GMAB | Genmab A/S | CPSE | Outperform | kr2.04k | kr2.71k | 0.00% | 14 | kr131.83B |
| SRT3 | Sartorius | XTRA | Outperform | 270.00€ | 281.57€ | 0.00% | 10 | 16.74€B |
| LH | Laboratory Corp of America Hol... | NYSE | Outperform | $206.83 | $241.28 | 0.00% | 9 | $17.43B |
| SGSN | SGS | SWX | Hold | CHF80.72 | CHF86.34 | 0.00% | 7 | CHF15.28B |
| DGX | Quest Diagnostics | NYSE | Outperform | $144.17 | $141.17 | 0.00% | 8 | $16.02B |
| BVI | Bureau Veritas | ENXTPA | Outperform | 27.38€ | 26.96€ | 0.00% | 12 | 12.88€B |
| MEDP | Medpace Holdings | NasdaqGS | Outperform | $397.25 | $281.20 | 0.00% | 2 | $12.34B |
| ERF | Eurofins Scientific | ENXTPA | Hold | 57.90€ | 0.00€ | 0.00% | 5 | 11.05€B |
| CRL | Charles River Laboratories Int... | NYSE | Outperform | $223.06 | $229.97 | 0.00% | 11 | $11.82B |
| REC | Recordati Industria Chimica e ... | BIT | Hold | 50.35€ | 48.61€ | 0.00% | 1 | 10.36€B |
| ITRK | Intertek Group | LSE | Outperform | £49.10 | £44.87 | 0.00% | 14 | £8.15B |
| CTLT | Catalent | NYSE | Hold | $55.00 | $49.29 | 0.00% | 3 | $10.10B |
| SHL | Sonic Healthcare | ASX | Hold | $26.61 | $34.12 | 0.00% | 0 | $12.78B |
| BANB | Bachem Holding | SWX | Hold | CHF90.60 | CHF616.00 | 0.00% | 2 | CHF6.25B |
| HIK | Hikma Pharmaceuticals PLC | LSE | Outperform | £19.73 | £28.11 | 0.00% | 9 | £4.42B |
| ZEAL | Zealand Pharma A/S | CPSE | Buy | kr600.00 | kr357.00 | 0.00% | 2 | kr38.52B |
| ORNBV | Orion Oyj | HLSE | Hold | 37.75€ | 42.52€ | 0.00% | 3 | 5.12€B |
| ABCM | Abcam | NasdaqGS | - | $23.99 | $19.25 | 0.00% | 0 | $5.52B |
| ALK B | ALK-Abelló A/S | CPSE | Outperform | kr152.00 | kr109.25 | 0.00% | 3 | kr33.91B |
| TECN | Tecan Group | SWX | Outperform | CHF333.20 | CHF406.33 | 0.00% | 3 | CHF4.40B |
| MOR | MorphoSys | XTRA | Hold | 68.10€ | 28.78€ | 0.00% | 3 | 2.52€B |
| SYNH | Syneos Health | NasdaqGM | - | $42.98 | $43.00 | 0.00% | 0 | $2.64B |
| INDV | Indivior PLC | LSE | Buy | £13.33 | £28.89 | 0.00% | 4 | £1.95B |
| ALM | Almirall | BME | Outperform | 9.47€ | 11.39€ | 0.00% | 3 | 1.94€B |
| GLPG | Galapagos NV | ENXTAM | Hold | 26.98€ | 39.85€ | 0.00% | 2 | 1.80€B |
| APPS | Applus Services | BME | Outperform | 12.72€ | 10.92€ | 0.00% | 3 | 1.63€B |
| CLIN | Clinigen | AIM | - | £9.25 | £7.78 | 0.00% | 0 | £1.23B |
| BIO3 | Biotest | XTRA | Hold | 27.70€ | 37.00€ | 0.00% | 0 | 1.38€B |
| VEC | Vectura Group | LSE | - | £165.00 | £1.55 | 0.00% | 0 | £1.00B |
| COPN | Cosmo Pharmaceuticals N.V. | SWX | Buy | CHF72.90 | CHF76.55 | 0.00% | 0 | CHF1.14B |
| FAE | Faes Farma | BME | Hold | 3.66€ | 3.90€ | 0.00% | 0 | 1.09€B |
| 4544 | H.U. Group Holdings | TSE | Outperform | ¥2.69k | ¥0.00 | 0.00% | 0 | ¥164.15B |
| ERGO | Ergomed | AIM | - | £9.84 | £14.90 | 0.00% | 0 | £490.82M |
| PHM | Pharma Mar | BME | Outperform | 35.94€ | 50.20€ | 0.00% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | SWX | Outperform | CHF43.65 | CHF65.63 | 0.00% | 0 | CHF529.94M |
| NIOX | NIOX Group Plc | AIM | Buy | £0.74 | £0.76 | 0.00% | 0 | £301.02M |
| DBV | DBV Technologies | ENXTPA | Outperform | 1.32€ | 4.07€ | 0.00% | 1 | 115.65€M |
| MOLN | Molecular Partners | SWX | Outperform | CHF3.31 | CHF9.50 | 0.00% | 1 | CHF110.77M |
